Search all trials

Find therapies in clinical trials near you – page 34

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Not recruiting

Registered drugNo placebo

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Diabetic neuropathy+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Adezunap

Contact Research Centre

Cardiac failure+1

Not recruiting

Investigational

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Azd3427

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drug

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Registered drugNo placebo

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Canagliflozin

Contact Research Centre

Small cell lung cancer

Not recruiting

Registered drug

Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Macular oedema+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Follicle centre lymphoma follicular grade I, II - III

Not recruiting

Registered drugNo placebo

Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Find therapies in clinical trials near you – page 34

418 trials match your criteria

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Non-small cell lung cancer

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Diabetic neuropathy+1

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Cardiac failure+1

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Ischaemic stroke

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Myelodysplastic syndrome

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Type 2 diabetes mellitus+3

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Small cell lung cancer

Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Macular oedema+1

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Follicle centre lymphoma follicular grade I, II - III

Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.